Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.

Tytuł:
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Autorzy:
Chatterjee S; Cornea and Anterior Segment Services, MGM Eye Institute, Raipur, Chhattisgarh, India.
Agrawal D; Cornea and Anterior Segment Services, MGM Eye Institute, Raipur, Chhattisgarh, India.
Gomase SN; Cornea and Anterior Segment Services, MGM Eye Institute, Raipur, Chhattisgarh, India.
Parchand SM; Vitreo-Retina Services, MGM Eye Institute, Raipur, Chhattisgarh, India.
Gangwe AB; Vitreo-Retina Services, MGM Eye Institute, Raipur, Chhattisgarh, India.
Mishra M; Oculoplasty and Ocular Oncology Services, MGM Eye Institute, Raipur, Chhattisgarh, India.
Źródło:
Indian journal of ophthalmology [Indian J Ophthalmol] 2022 Dec; Vol. 70 (12), pp. 4391-4398.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: Mumbai : Medknow Publications
Original Publication: Bombay : All-India Ophthalmological Society
MeSH Terms:
Fluoroquinolones*/pharmacology
Eye Infections*
Humans ; Moxifloxacin ; Gatifloxacin ; Cefuroxime ; Colistin ; Longitudinal Studies ; Retrospective Studies ; Ciprofloxacin ; Ofloxacin ; Anti-Bacterial Agents/pharmacology
References:
Ophthalmology. 1999 Jan;106(1):80-5. (PMID: 9917785)
Optom Vis Sci. 2021 Sep 1;98(9):1113-1121. (PMID: 34510155)
J Cataract Refract Surg. 2016 Dec;42(12):1841-1843. (PMID: 28007119)
Ophthalmology. 2000 Aug;107(8):1497-502. (PMID: 10919897)
Cornea. 2015 Jun;34(6):698-703. (PMID: 25811722)
Indian J Ophthalmol. 2019 Jan;67(1):49-53. (PMID: 30574892)
Clin Infect Dis. 2009 Dec 1;49(11):1749-55. (PMID: 19857164)
Indian J Ophthalmol. 2016 Feb;64(2):153-7. (PMID: 27050354)
Clin Ophthalmol. 2020 Jan 29;14:287-297. (PMID: 32099313)
Ophthalmology. 1999 Jul;106(7):1319-23. (PMID: 10406614)
J Ophthalmol. 2015;2015:813979. (PMID: 26576294)
JAMA Ophthalmol. 2020 May 1;138(5):439-450. (PMID: 32271355)
Eur J Ophthalmol. 2010 Mar-Apr;20(2):300-5. (PMID: 19924668)
JAMA Ophthalmol. 2015 Dec;133(12):1445-54. (PMID: 26502312)
Infect Genet Evol. 2019 Apr;69:203-210. (PMID: 30708134)
Br J Ophthalmol. 2017 Feb;101(2):108-113. (PMID: 27130916)
Indian J Ophthalmol. 2019 Sep;67(9):1508-1509. (PMID: 31436220)
Ophthalmology. 1999 Jul;106(7):1313-8. (PMID: 10406613)
Clin Infect Dis. 1997 Jan;24 Suppl 1:S67-73. (PMID: 8994781)
Clin Microbiol Rev. 2020 May 13;33(3):. (PMID: 32404435)
Clin Infect Dis. 2001 Mar 15;32 Suppl 1:S1-8. (PMID: 11249822)
PLoS One. 2018 Oct 18;13(10):e0205814. (PMID: 30335799)
Surv Ophthalmol. 2004 Mar;49 Suppl 2:S73-8. (PMID: 15028482)
Contributed Indexing:
Keywords: Antibiotic resistance; bacteria; endophthalmitis; fluoroquinolone; keratitis
Substance Nomenclature:
0 (Fluoroquinolones)
U188XYD42P (Moxifloxacin)
L4618BD7KJ (Gatifloxacin)
O1R9FJ93ED (Cefuroxime)
Z67X93HJG1 (Colistin)
5E8K9I0O4U (Ciprofloxacin)
A4P49JAZ9H (Ofloxacin)
0 (Anti-Bacterial Agents)
Entry Date(s):
Date Created: 20221201 Date Completed: 20221202 Latest Revision: 20230222
Update Code:
20240105
PubMed Central ID:
PMC9940527
DOI:
10.4103/ijo.IJO_1033_22
PMID:
36453351
Czasopismo naukowe
Purpose: To assess the fluoroquinolone resistance pattern and trends among bacterial isolates from ocular infections over a 16-year period and explore alternative antibiotics in fluoroquinolone-resistant strains.
Methods: In this retrospective, longitudinal study, the microbiology laboratory records of patients with different ocular infections diagnosed at an eye institute in central India from 2005-2020 were reviewed to determine the pattern of fluoroquinolone (ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin) resistance. Antibiotic susceptibility testing was done using the Kirby-Bauer disc diffusion method.
Results: In 725 Gram-positive bacteria, the resistance of ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin was 55.9% (95% confidence interval [CI]: 52.2 - 59.6), 42.7% (95% CI: 39.0 - 46.4), 47.6% (95% CI: 43.9 - 51.3), and 45.6% (95% CI: 41.7-49.5), respectively. In 266 Gram-negative bacteria, the resistance of ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin was 57.9% (95% CI: 51.9 - 63.9), 56.0% (95% CI: 49.7 - 62.1), 59.9% (95% CI: 53.8 - 66.0), and 74.3% (95% CI: 68.3 - 80.2), respectively. A declining trend in resistance to ciprofloxacin (P < 0.001), ofloxacin (P < 0.001), and moxifloxacin (P < 0.001) was seen in Gram-positive bacteria, whereas a reduction in resistance to only moxifloxacin (P = 0.04) was seen in Gram-negative bacteria. In fluoroquinolone-resistant Gram-positive bacteria, cefuroxime exhibited the highest susceptibility, whereas in fluoroquinolone-resistant Gram-negative bacteria, colistin exhibited the highest susceptibility.
Conclusion: Fluoroquinolone resistance was high among bacteria from ocular infections in central India, but a declining trend in resistance to some of the fluoroquinolones was observed in recent times. Cefuroxime and colistin emerged as alternatives in fluoroquinolone-resistant Gram-positive and Gram-negative bacterial infections, respectively.
Competing Interests: None
Comment in: Indian J Ophthalmol. 2022 Dec;70(12):4399. (PMID: 36453352)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies